Piramal Pharma Limited (PPLPHARMA.BO)
INR 221.45
(2.07%)
INR 221.45
(2.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 74 Billion INR | -4.5% |
| 2022 | 77.49 Billion INR | 27.02% |
| 2021 | 61 Billion INR | 268.37% |
| 2020 | 16.56 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 73.34 Billion INR | 0.0% |
| 2023 FY | 74 Billion INR | -4.5% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 70.17 Billion INR | 0.0% |
| 2023 Q4 | 74 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q2 | 69.98 Billion INR | 0.0% |
| 2022 FY | 77.49 Billion INR | 27.02% |
| 2022 Q4 | 77.49 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 61 Billion INR | 0.0% |
| 2021 FY | 61 Billion INR | 268.37% |
| 2020 FY | 16.56 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | -354.746% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 51.379% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | -1328.408% |
| Granules India Limited | 22.95 Billion INR | -222.398% |
| Indoco Remedies Limited | 10.34 Billion INR | -615.551% |
| Achyut Healthcare Limited | 2.01 Million INR | -3676223.895% |
| Ajanta Pharma Limited | 10.71 Billion INR | -590.965% |
| Alkem Laboratories Limited | 48.6 Billion INR | -52.257% |
| Alpa Laboratories Limited | 307.12 Million INR | -23996.092% |
| Brooks Laboratories Limited | 248.6 Million INR | -29668.344% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | -1921.366% |
| Bajaj HealthCare Limited | 4.86 Billion INR | -1420.326% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | -3409.228% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 30.816% |
| Eris Lifesciences Limited | 38.26 Billion INR | -93.384% |
| FDC Limited | 3.7 Billion INR | -1895.154% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | -13.659% |
| Gufic Biosciences Limited | 5.59 Billion INR | -1221.552% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | -3132.394% |
| Ipca Laboratories Limited | 33.74 Billion INR | -119.319% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -24837.458% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | -2388.451% |
| Lasa Supergenerics Limited | 541.92 Million INR | -13555.838% |
| Laurus Labs Limited | 42.71 Billion INR | -73.253% |
| Lupin Limited | 96.23 Billion INR | 23.102% |
| Mankind Pharma Limited | 23.87 Billion INR | -209.97% |
| Medicamen Biotech Limited | 940.36 Million INR | -7769.736% |
| Medico Remedies Limited | 438.24 Million INR | -16786.575% |
| Megasoft Limited | 1.85 Billion INR | -3893.453% |
| NATCO Pharma Limited | 10.53 Billion INR | -602.662% |
| RPG Life Sciences Limited | 1.38 Billion INR | -5261.861% |
| Sigachi Industries Limited | 2.53 Billion INR | -2823.613% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 59.686% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | -3537.958% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -6251.159% |
| Unichem Laboratories Limited | 8.06 Billion INR | -817.116% |
| Wanbury Limited | 3.15 Billion INR | -2245.239% |
| Windlas Biotech Limited | 1.76 Billion INR | -4098.355% |
| ZIM Laboratories Limited | 2.08 Billion INR | -3456.601% |
| Zydus Lifesciences Limited | 71.79 Billion INR | -3.082% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | -1801.01% |
| Divi's Laboratories Limited | 18.99 Billion INR | -289.702% |
| Hester Biosciences Limited | 3.59 Billion INR | -1958.697% |
| Procter & Gamble Health Limited | 2.56 Billion INR | -2789.442% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -9341.456% |
| Bal Pharma Limited | 2.51 Billion INR | -2846.884% |
| Strides Pharma Science Limited | 37.68 Billion INR | -96.4% |
| Venus Remedies Limited | 1.39 Billion INR | -5213.354% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | -796.947% |
| Nectar Lifesciences Limited | 11.21 Billion INR | -559.688% |
| Shilpa Medicare Limited | 12.93 Billion INR | -472.237% |
| Aarti Drugs Limited | 11.5 Billion INR | -543.293% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | -1069.309% |
| Suven Life Sciences Limited | 148.62 Million INR | -49694.04% |
| Ind-Swift Limited | 13.45 Billion INR | -450.097% |
| Valiant Laboratories Limited | 1.05 Billion INR | -6893.033% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | -591.113% |
| Solara Active Pharma Sciences Limited | 14.14 Billion INR | -423.229% |
| Themis Medicare Limited | 1.88 Billion INR | -3820.74% |
| Hikal Limited | 12.99 Billion INR | -469.488% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 9.806% |
| Sequent Scientific Limited | 8.27 Billion INR | -794.394% |
| Novartis India Limited | 1.8 Billion INR | -4008.845% |
| Wockhardt Limited | 39.87 Billion INR | -85.614% |
| Jubilant Pharmova Limited | 61.27 Billion INR | -20.776% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -25524.881% |
| Neuland Laboratories Limited | 5.49 Billion INR | -1245.886% |
| Morepen Laboratories Limited | 4.45 Billion INR | -1559.37% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -11393.455% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -3644.573% |